SYNAPDX
SynapDx's mission is to provide laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism. Autism Spectrum Disorders are currently estimated to affect 1 in 110 children in the United States according to the Centers for Disease Control. SynapDx was founded by Stanley Lapidus and closed a Series A round of venture funding in May 2010 from North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst Partners. SynapDx's corporate headquarters is located in Lexington, Massachusetts.
SYNAPDX
Industry:
Health Care Health Diagnostics Medical Device
Founded:
2010-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.synapdx.com
Total Employee:
11+
Status:
Closed
Contact:
+1 781 250 2844
Total Funding:
32.4 M USD
Technology used in webpage:
Viewport Meta SPF Domain Not Resolving SSL By Default Google Tag Manager Apple Mobile Web Clips Icon Google Font API Google Analytics HSTS Content Delivery Network
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
LucyDx
LucyDX is on a mission to prevent blindness in diabetics through early detection.
NinePoint Medical
NinePoint Medical is a transformational medical device company developing innovative, real-time, in vivo pathology devices.
Seno Medical Instruments
Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Bobbi Rathmell Vice President and Medical Director @ SynapDx
Vice President and Medical Director
Founder
Investors List
LabCorp
LabCorp investment in Venture Round - SynapDx
Google Ventures
Google Ventures investment in Venture Round - SynapDx
The Kraft Group
The Kraft Group investment in Venture Round - SynapDx
The Kraft Group
The Kraft Group investment in Venture Round - SynapDx
LabCorp
LabCorp investment in Series C - SynapDx
General Catalyst
General Catalyst investment in Series B - SynapDx
North Bridge Venture Partners & Growth Equity
North Bridge Venture Partners & Growth Equity investment in Series B - SynapDx
Bain Capital Ventures
Bain Capital Ventures investment in Series A - SynapDx
General Catalyst
General Catalyst investment in Series A - SynapDx
North Bridge Venture Partners & Growth Equity
North Bridge Venture Partners & Growth Equity investment in Series A - SynapDx
Official Site Inspections
http://www.synapdx.com
- Host name: server54-5.web-hosting.com
- IP address: 198.54.126.121
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "SynapDx"
SynapDx - Crunchbase Company Profile & Funding
SynapDx. was founded by Stanley Lapidus and closed a Series A round of venture funding in May 2010 from North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst …See details»
SynapDx 2025 Company Profile: Valuation, Funding
SynapDx General Information Description. Provider of blood-based diagnostic tests and equipment intended to be used for the early detection of autism. The …See details»
Company Information - RocketReach
SynapDx is a private company developing laboratory diagnostic services for autism and neurodevelopmental disorders, with the initial goal of enabling earlier detection of autism …See details»
SynapDx - VentureRadar
SynapDx was founded in 2010 and is based in Lexington, Mass. Members of the board of directors are: Hemant Taneja, Partner at General Catalyst, Bob Carpenter, former Lead …See details»
SynapDx - Funding, Financials, Valuation & Investors - Crunchbase
SynapDX is an early-stage laboratory services company developing blood-based diagnostic tests for the early detection of autism. New. Resources. ... How much funding has this organization …See details»
SynapDx - Overview, News & Similar companies | ZoomInfo.com
SynapDx was founded in 2010 and is based in Lexington, Mass. Read more. SynapDx's Social Media. Is this data correct? View contact profiles from SynapDx. Popular Searches Synapdx …See details»
SynapDx - Contacts, Employees, Board Members, Advisors & Alumni
Organization. SynapDx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... and Advisor Profiles 3. About. SynapDx has 1 current …See details»
SynapDx Corp - Company Profile and News - Bloomberg Markets
Company profile page for SynapDx Corp including stock price, company news, executives, board members, and contact informationSee details»
Synapdx Corp. (MD): Drug pipelines, Patents, Clinical trials - Synapse
Jul 13, 2023 Explore Synapdx Corp. (MD) with its drug pipeline, therapeutic area, technology platform, .See details»
271680340 EIN/TAX ID | SYNAPDX CORP. - HIPAASpace
SYNAPDX CORP. Conformed submission company name, business name, organization name, etc CIK: 1492969: Company's Central Index Key (CIK). The Central Index Key (CIK) is used …See details»
SynapDx
SynapDx is developing a blood test to help physicians identify children at high risk of autism spectrum disorder (ASD) earlier than they do today. Despite increased prevalence and …See details»
SynapDx Corporation Raises $9 Million in Series A Funding - PR …
Jun 1, 2010 /PRNewswire/ -- SynapDx Corp., a new company focused on developing and commercializing diagnostic testing for the early detection of autism, announced the...See details»
SynapDxRaises $6M - FinSMEs
Dec 11, 2012 SynapDx Corporation, a Southborough, Mass.-based developer of blood-based diagnostic test designed to identify children with autism spectrum disorders (ASD) by age 36 …See details»
SynapDx and the Broad Institute link to use next-gen sequencing …
Mar 17, 2014 Startup SynapDx will team with the famed Broad Institute of Harvard and MIT to advance next-generation DNA sequencing for more accurate and clinically useful autism …See details»
SynapDx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Feb 9, 2025 SynapDX is an early-stage laboratory services company developing blood-based diagnostic tests for the early detection of autism. ... Log In. Experience the new Crunchbase, …See details»
SynapDx Genetics & Genomics News | GenomeWeb
NEW YORK (GenomeWeb News) – SynapDx today announced a collaboration with the Broad Institute to develop next-generation sequencing analysis methods to improve autism …See details»
Google leads SynapDx's $15.4M funding round | Fierce Biotech
Jul 22, 2013 The Massachusetts startup turned to Google Ventures to lead the round. | SynapDx's has wrapped up $15.4 million in new funding to help advance a 660-patient study …See details»
BioCentury - SynapDx raises $15.4 million
Jul 22, 2013 Diagnostics company SynapDx Corp. (Lexington, Mass.) raised $15.4 million in a venture round led by new investor Google Ventures. New investor Foundation Medical …See details»
SYNAPDX CORP. Top 13F Holdings - WhaleWisdom.com
Synapdx Corp. is based out of Lexington. The firm last filed a Form D notice of exempt offering of securities on 2013-07-25. The notice included securities offered of EquitySee details»
Synapse - Global Drug Intelligence Database
Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D intelligence through …See details»